ANIP - ANI Pharmaceuticals gets FDA approval for generic levocarnitine tablets
- ANI Pharmaceuticals ( NASDAQ: ANIP ) on Monday said it had got U.S. Food and Drug Administration (FDA) approval for its generic version of the drug carnitor.
- The FDA approval was for ANIP's levocarnitine tablets, 330 mg.
- ANIP's levocarnitine tablets are a generic version of the drug carnitor.
- Carnitor is a medicine used to treat symptoms of end-stage renal disease and carnitine deficiency.
- "The current annual U.S. market for Levocarnitine Tablets is approximately $10.0 million," ANIP said in a statement , citing data from IQVIA/IMS Health.
- ANIP stock earlier closed marginally higher at $38.11.
For further details see:
ANI Pharmaceuticals gets FDA approval for generic levocarnitine tablets